| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.04. | Myriad Genetics, Inc.: New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen | 1 | GlobeNewswire (USA) | ||
| 11.04. | Myriad Genetics (MYGN) Announces Favorable Research Results | 2 | Zacks | ||
| 09.04. | Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now | 1 | Zacks | ||
| 27.03. | Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay | 3 | Zacks | ||
| 22.03. | Myriad Genetics, Inc.: Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date | 118 | GlobeNewswire (Europe) | SALT LAKE CITY, March 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark... ► Artikel lesen | |
| 20.03. | Myriad Genetics secures patent for fetal sex test technology | 1 | Investing.com | ||
| 20.03. | Myriad Genetics, Inc.: Myriad Genetics Announces Patent Granted for SneakPeek Snap Device | 65 | GlobeNewswire (Europe) | SALT LAKE CITY, March 20, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the U.S. Patent and Trademark Office... ► Artikel lesen | |
| 01.03. | Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact | 2 | Zacks | ||
| 28.02. | Myriad Genetics, Inc. (MYGN) Q4 2023 Earnings Call Transcript | 2 | Insider Monkey | ||
| 28.02. | MYRIAD GENETICS INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 28.02. | Myriad Genetics (MYGN) Q4 Earnings Top Estimate, Margins Down | 2 | Zacks | ||
| 28.02. | Earnings call: Myriad Genetics reports positive 2023 results, eyes growth | 2 | Investing.com | ||
| 28.02. | Myriad Genetics Inc reports results for the quarter ended in December - Earnings Summary | 4 | Reuters | ||
| 27.02. | Myriad Genetics: Q4 Earnings Insights | 2 | Benzinga.com | ||
| 27.02. | Myriad Genetics Non-GAAP EPS of $0.04 beats by $0.03, revenue of $196.6M beats by $1.97M | 2 | Seeking Alpha | ||
| 27.02. | Myriad Genetics Inc. Q4 Earnings Summary | 256 | AFX News | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Myriad Genetics Inc. (MYGN):Earnings: -$31.2 million in Q4 vs. -$42.3 million in the same period last year.
EPS: -$0.36 in Q4 vs.... ► Artikel lesen | |
| 27.02. | MYRIAD GENETICS INC - 8-K, Current Report | 3 | SEC Filings | ||
| 27.02. | Myriad Genetics, Inc.: Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjuste | 89 | GlobeNewswire (Europe) | Highlights: Full-year testing volume grew 35% year-over-year, or 18% ex-SneakPeek® volume.Full-year 2023 revenue of $753 million, grew 11% year-over-year driven by Prenatal (30%, 15% ex-SneakPeek)... ► Artikel lesen | |
| 27.02. | Myriad Genetics, Inc.: Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3 | 2 | GlobeNewswire (USA) | ||
| 26.02. | Myriad Genetics Q4 2023 Earnings Preview | 1 | Seeking Alpha |
Seite:
1 2 3 4 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TUI | 3.740 |
| NVIDIA | 3.623 |
| TESLA | 3.029 |
| SUPER MICRO COMPUTER | 2.920 |
| BAYER | 2.806 |
| VARTA | 2.499 |
| NEL | 2.453 |
| RHEINMETALL | 2.347 |
| DEUTSCHE BANK | 1.764 |
| RENK GROUP | 1.753 |
| SAP | 1.539 |
| AIXTRON SE | 1.523 |
| DEUTSCHE LUFTHANSA | 1.469 |
| BASF | 1.363 |
| EVOTEC | 1.354 |
| BYD | 1.331 |
| ALLIANZ | 1.151 |
| PLUG POWER | 1.119 |
| RWE | 1.085 |
| COMMERZBANK | 1.067 |
| INFINEON | 1.064 |
| MERCEDES-BENZ | 960 |
| VOLKSWAGEN | 916 |
| THYSSENKRUPP | 913 |
| NORDEX | 872 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
